chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Consumer reported that she found out that she was pregnant after she received first and only dose of GARDASIL 9.   The patient received the vaccine on 1/3/2023.   No additional AEs were reported. No further information provided.  No PQC.; No aditional AE reported; This prospective spontaneous report has been received from a consumer, regarding to herself, a 33-years-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 03-JAN-2023, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, as prophylaxis (strength, dose, scheme, route and anatomical location of administration, lot number and expiration date were not reported).  After the administration of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), the patient discovered she was pregnant. By the time of the report the patient was 16 weeks pregnant, with a calculated last menstrual period on 17-JAN-2023. (Exposure during pregnancy) Pregnancy and fetal outcome were pending and unknown by the time of the report.  On unspecified dates, the patient got performed blood test and an ultrasound, but the results were not reported.  No additional adverse event was reported.
On 01/22/2023 I had a fever of 101.0 and had a headache. I was fatigued also.
Developed a stiff neck after a week or so and thought nothing of it  until now because it is not going away.   Also , I developed an itchy pimply rash on my lower back that is  troublesome and for which I am using benedryl.  The asprin  nor the aleve seem to help the neck.  The itchy is driving me nuts--benedryl helps a little.  SHOULD I GET MY SECOND DOSE WHICH IS DUE FEBRUARY 10?
Swelling right anterior thigh. Painful (not bruised. not erythematous). Refusing to walk.
Patient developed congestion, coughing, persistent fever, and loss of appetite.  She was seen in urgent care on 12/5/2010, diagnosed with ear infection and prescribed antibiotics.  Fever persisted and symptoms worsened.  She was seen in urgent care again on 12/9/2010, 12/11/2010, and 12/12/2010.  During her 12/12/2010 there was a chest Xray taken and they confirmed that she had pneumonia.  She was hospitalized for two nights, 3 days.  She is still under treatment for coughing and persistent ear infection.
I contracted COVID-19 with symptoms of severe headache, body aches, fever 100.1 to 100.6, insomnia, urge to cough, congestion, chest pain, lack of appetite, disorientation, chills, and fatigue. I was not able to take PAXLOVID due to taking rosuvastatin. The fever resolved after 5 days. My symptoms began to resolve after 9 days of illness. I am still experiencing lingering fatigue.
mom reports had high pitch crying for 2-3 hrs beginning immediately p/vax; No further problems were noticed was seen @ ER; no tx or test given x/APAP;
Started with sore throat on first day. Symptoms progressed to coughing and stuffy/runny nose o day 2. Tested positive for Covid on day 3.  Additional symptoms of muscle/joint pain and headache on day 3. Symptoms Started subsiding on Day 4. Day 5 had nausea and diarrhea. Felt better on day 6 with just congestion in nose and post nasal drip. Continuing to improve on day 7.
I have a tingling sensation on my fingertips 3 days after shot.  My face is tingling, my lips tingle.; I have a tingling sensation on my fingertips 3 days after shot.  My face is tingling, my lips tingle.; This is a spontaneous report from a contactable consumer(patient). A 55-year-old male patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot/batch number not provided), via an unspecified route of administration on 06Mar2021 at 10:45 (at the age of 55-years-old) into right arm as a single dose for COVID-19 immunization at pharmacy or Drug Store. The patient medical history included high blood pressure, prediabetic, high cholesterol, rosacea. Prior the vaccination, patient was not diagnosed with COVID. Post vaccination, patient was not tested for COVID. The concomitant medications were farxiga, victoza, doxyclycline. Patient had allergies to codiene, shrimp. Patient did not receive any other vaccine in four weeks. On 07Mar2021 at 06:00 am, the patient experienced tingling sensation on my fingertips 3 days after shot. His face was tingling, lips tingle. No treatment was given for the events. The outcome of the events was not recovered.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
SEVERE REDNESS SORENESS AND PAIN AT INJECTION SITE. HE WENT TO HIS DOCTOR STATES STILL HAVING PAIN AND SITE SORENESS 5 DAYS AFTER SHOT. DR TOLD HIM NOT TO GET SECOND DOSE
Pancreatic cancer (SMARCB/INI deficiency malignancy). Portal vein thrombus. Blood clots. Possible metastatic disease after Whipple surgery, despite ongoing chemotherapy (folfox).
Patient reported that she went to ER on 8/11/2021 with stroke like symptoms and ER informed her she did not have stroke.  She reported feeling confused, slurry speech, not able to walk straight and appetite. Denied fever, hallucinations and chills. Patient reported that she went to her primary care doctor yesterday and she received hydration IV and she reported feeling better today and that she went back to work.
This was following my 2nd dose of Pfizer COVID vaccine. About 1:00am (~16-17 hours later) woke up with site injection arm hurting and a fever. About 30 minutes later it felt like something was pressing down on my chest and I couldn't breath. It lasted maybe 5-10 minutes and I felt normal again. So I went back to sleep to hopefully get rid of the fever. No other issues since then.
sinus infection; asking if Doxycycline with interfere or interact with the vaccine; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,/Lot number: not reported), dose 1 via an unspecified route of administration on 15Apr2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. on an unspecified date,the patient experienced sinus infection, asking if doxycycline with interfere or interact with the vaccine. Question: Caller is a consumer, asking if Doxycycline with interfere or interact with the vaccine. Caller reports that she received her first vaccine dose on 15Apr2021 and is scheduled for her second dose on 05May2021 but since her first dose she has been diagnosed with a sinus infection and was prescribed Doxycycline antibiotic. She reports "I read on the fact sheet that you shouldn't take other vaccines when getting the covid vaccine and I want to know if it is safe to take my antibiotic for 10 days if I'm planning to get my second shot". Caller reports that she already talked to her doctors PA wh'o advised her that it was ok to take the antibiotic, but she stated "He's new and I don't trust him yet".  Caller also asks "When can I restart my other medicine" reporting that she was advised to hold her medications, no specific medicine specified, but wasn't told when to restart them. The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
90 minutes of continuous, uncontrollable, chills-shakes, about 12 hours after vaccine injection; 90 minutes of continuous, uncontrollable, chills-shakes, about 12 hours after vaccine injection; Also had 24- 36 hours of constant, severe headaches which started about 12 hours after vaccine; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 08:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 20:00, about 12 hours after vaccine, the patient experienced 90 minutes of continuous, uncontrollable, chills-shakes and also had 24-36 hours of constant, severe headaches. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 90 minutes of continuous, uncontrollable, chills-shakes were resolved on 29Mar2021; while that of the event had 24-36 hours of constant, severe headaches was resolved on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 08:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Had 20 minute generalized partial seizure very agitated, eyes rolled unresponsive.
Sudden hearing decreased; Tinnitus; Sensitivity to noise in left ear; This is a spontaneous report from a contactable physician. A 53-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3243) via an unspecified route of administration in the arm right on 16Jan2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, glaucoma, migraine, cervical radiculopathy and pre-diabetes. The patient received unspecified prescribed medication within two weeks prior to COVID-19 vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL1284) via intramuscular route of administration in the arm left on 26Dec2020 at 11:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 01Apr2021 at 21:00, the patient experienced sudden hearing decreased, tinnitus and sensitivity to noise in left ear(hyperacusis). The patient did not receive any treatment for the reported events. The adverse events resulted in doctor or other healthcare professional office/clinic visit. On 01Apr2021, the patient underwent SARS-CoV-2 test (PCR test) through nasal swab and the result was negative. The clinical outcome of the events sudden hearing decreased, tinnitus and sensitivity to noise in left ear were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Narrative:  Pt presented to ER 8/10/2022. He reports symptoms as early as 8/3/2022. Pt reports cold symptoms (cough, congestion, HA, stuffy nose, sore throat). Pt admitted 8/10/22 - 8/22/22. HOSPITAL COURSE: Pt was admitted to SDU w COVID-19 infection Pt presented with acute hypoxic respiratory failure, was weaned from O2 thru the course of this admission. He was Vaccinated with moderna x 2, no boosters given, was in isolation until 8/2/22. Pt recieved 2 doses Remdesivir then kidney function decreased. there was no indication for Decadron. Pt has a cough and weakness with infection. Is on RA w O2 sats >94%. He had Acute left lower lobe pulmonary embolism found by VQ scan elevated d dimer 2.85, Most likely due to COVID-19. Was transitioned from therapeutic lovenox to Eliquis. no over s/sx bleeding and pt does not need supplemental O2. Pt had a Large exudative left pleural effusion, Most likely due to COVID-19 and CHF. S/P pigtail placement on 08/11/2022 and discontinued on 08/14/2022, had a small pntx post removal, which resolved spontaneously, cytology negative for malignancy. Pts Acute on chronic diastolic congestive heart failure, related to CAD, was managed by diuressis, BB, he is now Compensated, w/o central or peripheral edema. Due to age and kidney function he is not on a statin, risks outweigh benefits. Patient had Acute kidney failure superimposed on chronic kidney disease, stage 3. Creatinine = 1.8 --> 2.6 --> 2.7 (2.8 on 03/01/2022), -Most likely due to COVID- 19 and aggressive diuresing. he had some acidosis and was treated with bicarb. Also still has higher potassium levlels, was hyperkalemic on admission K+ 5.9, was on patiormir and remains on low potassium diet. Also he has primary hypertension, BP meds were held due to AKI and gradually added back. BP this am high so home dose meds were increased and hydralazine tid was added. Patient lives alone and cooks own meals or has them brought in by family, he has Diabetes mellitus type 2. had some hypoglycemia this admission but his A1c = 8.8%. Is on glargine, will need to f/u closely w dietary and PCP as outpt Pt also has Chronic obstructive pulmonary disease, No acute exacerbation this admission. he remains on home dose bronchodilators. NO shortness of breath or wheezing at dc. Pt is afebrile, hemodynamically stable, and is ambulating w walker, had BM, and is working w PT/ bands. Will dc to STR today.
This spontaneous report as received from a Nurse practitioner, refers to a female patient of unknown age with no pertinent medical history reported and no drugs reactions or allergies reported. By "the end of January 2013" the patient was vaccinated with a single dose of ZOSTAVAX (lot number and expiration date not provided) (0.65ml, subcutaneous, anatomical location not reported0 for immunization to prevent shingles. No other co-suspects or concomitant medications were reported. On 29-JAN-2013 the patient developed a shingles like rash at the injection site, where she was given ZOSTAVAX. The patient sought unspecified medical attention. The patient's primary care physician did a culture of the rash and prescribed an antiviral medication for the patient. At the time of the report the outcome of the shingles like rash at the injection site was unknown. Additional information has been requested.
Upon receiving the second Pfizer Covid 19 vaccine, the long-term side from the first dose had not resolved (See E-Report number:662080). Summary of effects included: Bilateral lymph node swelling and pain starting in the armpit on the side of vaccination that continued to spread through the week to breasts: ribs, collar bones, neck, back/shoulder blades, ears: hips groin; and extremities with calf pain/cramps; tinnitus in right ear; sore throat; and extreme fatigue. After receiving the second dose of the Pfizer Covid 19 vaccine, the above initial effects from the first dose were heightened. Existing pain and fatigue increased. In addition, I experienced ?typical? side effects: HA, chills, nausea, diarrhea, and stomach pain.  The heightened effects of the second dose remained for over two weeks. In the third week, the ear and throat pain subsided. At the time of this report- 25 days post vaccine- the lymphatic swelling/pain remains in both armpits and collar bone/shoulder region and the right side groin. Tinnitus still present.
Pt recvd Engerix-B had diarrhea, flu-like sx, malaise, fever;
June 1st, 2021, 3 weeks after his second Pfiser covid shot.     That morning he had his am coffee, no more than usual,  was having skips every 8 beats, then went up to every 3 beats, at one point they felt like heart rhythm was just all over the place. It finally stopped right before he called 911. The chest pain was actually quite severe for a few hours after that episode. Suddenly had had BOUTS of runs of extra heart beats or skipped beats that would last 30 seconds to 5 minutes. At least once a day. Plus he has isolated skips if he changed positions. Toward the end of that first week, he would lean forward to try to help the pain/palpitations. When he bent over that seemed to help the PAC's, (before June that would stop them, but after June 1st this maneuver was less effective.)  Often the PAC's would also get worse if he ate a lot and was digesting food.   His saw his PCP and had a 24 hour holter monitor. PAC's were seen. EKG was ok at the PCP's office.  June 8th he started taking doxycycline 100mg twice a day so has been on that 2 months. Within 4 days of the doxy the PAC's went from 50 or more a day, down to 4 a day. The chest pain lasted until about 2 weeks ago. It is slightly there still. He feels like there is a pulling in his chest. It waxes and wanes a lot. It increases with the pounding sensation.   Some of his old symptoms from when he was 29 came roaring back to full strength simultaneously and have been very persistent and present. The chest pain, the full body buzzing, feeling and muscle fasciculations- really bad the first week of June, better now. . The racing heart, the overclocked feeling(like excess energy he could not get rid of, like a lot of caffeine and sugar) and  the pounding heart. The skipped-beat-related-malaise. He could not get out of bed the latter 1/2 of the 1st week of June, as whenever he tried to stand up he would feel a lot worse and the chest pain would get worse. He would have to sit crosslegged on the bed, hunched over/leaning forward. He had to sleep on his stomach.  He has not had any sun rash from the doxycycline. After the round of Lyme 3 years ago he had tiny pin prick dots all mostly on his arms. Also red nodules on skin. They have been there ever since. Stopped showing up about 6 months after the Lyme happened. But when the chest pain started he got new lesions, and the older ones  seem more prominent.   His joint pain was way worse the first week of June, his knees and his elbows would get hot. His knees just ache all the time and elbows and neck, occasionally his ankles. He also would have severe muscle spasms, especially in his right calf. It can get angry if he walks too much. Sometimes he can run through it.   He started back brisk walking and jogging 3 times a week the last couple of weeks. The chest pain does get a little worse while running and fades an hour after.
2 x 1 1/2 inch area of redness at DTaP injection site.
Generally terrible; low grade temperature ranging from 99-101; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Generally terrible) and PYREXIA (low grade temperature ranging from 99-101) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced FEELING ABNORMAL (Generally terrible) and PYREXIA (low grade temperature ranging from 99-101). At the time of the report, FEELING ABNORMAL (Generally terrible) and PYREXIA (low grade temperature ranging from 99-101) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, Body temperature: 99-101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Post vaccine day 5 (6/18/22) noted smooth area of itchiness and mild redness to right lateral upper breast without induration or warmth, no drainage, no vesicle.  Area expanded in size and redness to maximum 7cm x4cm still without induration or warmth, positive blanching,  no drainage. No evidence of insect bite. No palpable lymph node. No fever or chills.  On  6/23/22 due to concern for possible cellulitis started Keflex 500 mg BID.  On 6/25/22 Keflex increased to 500mg TID and added Doxycycline 100mg BID for broadened antibiotic coverage due to progression of reddened area to the max of 7cm x4cm.  Now on 6/27/22, 9 days post presentation, area slightly regressing in size and color.
I had sweats, chills, and vomiting straight for 17 hrs. .. With 2nd shot, same thing chills, sweats,  and  vomited 13 hrs. Was on prednisone 2.5 weeks. But not on the day of vaccination.
Since Pfizer vaccine ongoing joint pain & knee joints sometimes just go out when stand up - especially low back   - all new issues after vaccine thought would go away - still occurs
Osteonecrosis of the jaw; A spontaneous report was received from a consumer concerning a 48 years-old female patient who received Moderna's Covid 19 vaccine (mRNA1273) and developed osteonecrosis of jaw.  The patient's medical history included active breast cancer with bone metastasis. Products known to have been used by the patient, within two weeks prior to the event, included denosumab.   The patient received first of two planned dose of mRNA-1273 (Lot # 015M20A) intramuscularly on 10-FEB-2021 for prophylaxis of Covid 19 infection.  On an unknown date in Feb 2021, after vaccination, the patient discovered that she had osteonecrosis of the jaw. The patient had bone exposed in the jaw about a week after getting the vaccine. Patient took a bone density drug, Xgeva (denosumab).  Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the event Osteonecrosis of jaw was unknown.; Reporter's Comments: Based on the current available information, the pathogenesis of osteonecrosis formation and mechanism of action of mRNA-1237 vaccine, the event of osteonecrosis of jaw is assessed as unlikely related. The patient's medical history of active breast cancer with bone metastasis is a contributing factor and confounds causality assessment. Further information has been requested.
No patient harm. Patient was given a Proquad plus a Varicella. Patients mother informed. Instructed to call if any reactions or symptoms.
sore a little bit; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the first Shingle shot and had still sore a little bit. The follow-up would not possible as no contact details were available.
Information has been received via a company representative, from a healthcare professional (office worker) who was vaccinated (date unspecified) with a dose of Gardasil, and subsequently developed a bump under her skin at the injection site.  At the time of this report, the patient had not recovered.  The patient sought unspecified medical attention.  Additional information has been requested.
Began with numbness in left leg after receiving the vaccine. In late January, the numbness became a limp. An EMG and NCV was ordered and here damage was found. After 2 years of onset, symptoms have only worsened.